Published in Gut on September 28, 2007
Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol (2010) 2.61
Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97
The economic burden of Clostridium difficile. Clin Microbiol Infect (2011) 1.74
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2012) 1.67
Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med (2011) 1.48
Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011. J Pediatr Gastroenterol Nutr (2015) 1.46
Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf (2013) 1.31
Clostridium difficile infection: new insights into management. Mayo Clin Proc (2012) 1.23
Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist (2014) 1.21
Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci (2009) 1.14
Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. Gastroenterol Res Pract (2011) 1.11
Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect Immun (2010) 1.08
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol (2013) 1.03
Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol (2012) 1.03
Clostridium difficile in the ICU: the struggle continues. Chest (2011) 1.01
Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol (2012) 1.01
The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Therap Adv Gastroenterol (2013) 1.00
Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol (2010) 0.97
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2014) 0.95
Genetic risk factors for Clostridium difficile infection in ulcerative colitis. Aliment Pharmacol Ther (2013) 0.95
Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.93
Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci (2014) 0.92
Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl (2012) 0.90
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol (2014) 0.87
Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent? Gut (2008) 0.87
Clostridium difficile 027 infection in Central Italy. BMC Infect Dis (2012) 0.86
The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci (2014) 0.86
Review of medical and surgical management of Clostridium difficile infection. Tech Coloproctol (2010) 0.85
WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg (2015) 0.85
Clostridium difficile infection worsens the prognosis of ulcerative colitis. Can J Gastroenterol Hepatol (2014) 0.84
Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study. BMC Pediatr (2014) 0.84
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease. Antimicrob Agents Chemother (2014) 0.83
Infections and Chronic Inflammatory Bowel Disease. Viszeralmedizin (2014) 0.82
Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection. Aliment Pharmacol Ther (2016) 0.81
Thinking beyond the colon-small bowel involvement in clostridium difficile infection. Gut Pathog (2009) 0.81
Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study. Am J Gastroenterol (2016) 0.80
Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control (2012) 0.80
Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review. World J Gastroenterol (2014) 0.79
Effects of Clostridium difficile infection in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol (2014) 0.78
Clostridium difficile infection in patients with inflammatory bowel disease. Ann Gastroenterol (2011) 0.78
Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis (2015) 0.78
IBD: Poor outcomes after Clostridium difficile infection in IBD. Nat Rev Gastroenterol Hepatol (2012) 0.78
Current Treatment Options for Severe Clostridium difficile-associated Disease. Gastroenterol Hepatol (N Y) (2008) 0.77
Clostridium difficile infection in patients with inflammatory bowel disease. Prz Gastroenterol (2014) 0.77
Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis (2015) 0.77
Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case-control study. BMC Infect Dis (2014) 0.77
An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection. PLoS One (2016) 0.77
Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol (2017) 0.77
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol (2016) 0.76
Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease. Inflamm Bowel Dis (2016) 0.75
Prognosis in Clostridium difficile infection complicating inflammatory bowel disease. Gut (2008) 0.75
Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease. Sci Rep (2016) 0.75
Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol (2016) 0.75
Vancomycin Use for Pediatric Clostridium difficile Infection is Increasing and Associated with Specific Patient Characteristics. Antimicrob Agents Chemother (2013) 0.75
Clostridium difficile and inflammatory bowel disease: implications for current clinical practice. F1000 Med Rep (2009) 0.75
Determination of serum antibodies to Clostridium difficile toxin B in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2012) 0.75
Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. World J Gastroenterol (2014) 0.75
Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis (2016) 0.75
The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis. Saudi J Gastroenterol (2015) 0.75
Management of Clostridium difficile Infection. Gastroenterol Hepatol (N Y) (2016) 0.75
Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis (2016) 0.75
Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. Gastroenterol Hepatol (N Y) (2013) 0.75
The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Curr Treat Options Gastroenterol (2017) 0.75
The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals. Front Nutr (2017) 0.75
The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases. Dig Dis Sci (2015) 0.75
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One (2017) 0.75
Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis. Inflamm Bowel Dis (2017) 0.75
Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol (2017) 0.75
Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol (1999) 2.11
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther (2005) 1.96
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene (2006) 1.56
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut (2007) 1.18
Integrin alpha E(CD103)beta 7 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin-independent interaction. J Immunol (2001) 1.15
Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest (2005) 1.06
Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am J Gastroenterol (2000) 1.03
Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun (1999) 0.98
Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease. Aliment Pharmacol Ther (2013) 0.95
Polypharmacy and Crohn's disease. Aliment Pharmacol Ther (2005) 0.94
Radiation induced small bowel "web" formation is associated with acquired microvascular dysfunction. Gut (2005) 0.91
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy. Aliment Pharmacol Ther (2010) 0.90
Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with hepatitis C or HIV. J Viral Hepat (2010) 0.89
Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease. J Pediatr (1998) 0.83
Cutaneous Crohn's disease mimicking Melkersson-Rosenthal syndrome: treatment with methotrexate. J Eur Acad Dermatol Venereol (2006) 0.83
Feasibility and safety of endoscopic evaluation of gastric emptying. Endoscopy (2005) 0.82
Novel model of peripheral tissue trauma-induced inflammation and gastrointestinal dysmotility. Neurogastroenterol Motil (2011) 0.81
The role of endoscopy in inflammatory bowel disease. Med Clin North Am (1994) 0.81
Antiangiogenic therapy in human gastrointestinal malignancies. Gut (2006) 0.79
Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction. Inflamm Bowel Dis (2001) 0.79
Terminal ileum resection is associated with higher plasma homocysteine levels in Crohn's disease. J Clin Gastroenterol (2001) 0.79
Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol (2000) 0.77